With the accessibility of targeted anticancer drugs receiving increasing attention, the generic version of Cobimetinib launched by Lao Bear Pharmaceut···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 163
Laos Daxiong version of Avatrombopag, as a novel thrombopoietin receptor agonist, provides a convenient and effective oral treatment option for patien···【Read More】
Update: 2026-06-10Source: Haiou HealthViews: 169
The Lao Big Bear version of Avatrombopag is a compliantly manufactured generic drug, providing patients with thrombocytopenia a treatment option that ···【Read More】
Update: 2026-06-09Source: Haiou HealthViews: 137
As a targeted drug focusing on the core pathological link of thrombocytosis, the Lao Big Bear version of Anagrelide not only continues the efficacy me···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 161
The Lao Bear version of Anagrelide is an oral antiproliferative drug for essential thrombocythemia, which precisely reduces platelet count by inhibiti···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 155
In the treatment landscape for elevated platelet counts caused by myeloproliferative neoplasms, the Laos Daxiong version of Anagrelide,凭借规范的仿制工艺与与原研药等···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 158
The Ibrutinib (ILUDX) produced by Laos Big Bear Pharmaceuticals is a high-quality oral BTK inhibitor generic drug. While retaining the same core ingre···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 223
While the insured price of the imported original drug Ibrutinib can still be several thousand yuan per box, the Lao Big Bear Pharmaceutical version ha···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 165
The Lao Bear Pharmaceuticals version of Ibrutinib, brand name ILUDX, is an oral BTK inhibitor used to treat various B-cell malignancies, offering a mo···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 193
The appearance of the Lao Dabear version of Mobocertinib has not only broken the monopoly of high-priced original drugs but has also become a highly a···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 145
As the first Southeast Asian generic option for the originator drug Mobocertinib, the Laos Dabear version of Mobocertinib brings new hope to patients ···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 146
The Lao Daewoong version of Mobocertinib is an oral targeted drug for non-small cell lung cancer with EGFR exon 20 insertion mutation. It is a high-qu···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 140
In the global pharmaceutical landscape where innovative drugs and generics coexist, the Lao Big Bear version of Acalabrutinib, with its strict quality···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 153
As an important generic version of the Bruton's tyrosine kinase (BTK) inhibitor, the Laos Dabear version of Acalabrutinib is helping more patients···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 185
The acalabrutinib generic version launched by Lao Bear Pharmaceutical provides cancer patients worldwide with a new cost-effective treatment option be···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 150
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos